probucol has been researched along with Complication, Postoperative in 3 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Probucol is a lipid-lowering drug that has an antioxidant effect." | 2.70 | Effect of antioxidant probucol for preventing stent restenosis. ( Cha, KS; Han, JY; Kim, HJ; Kim, JS; Kim, MH, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krackhardt, F | 1 |
| Rosli, MA | 1 |
| Leschke, M | 1 |
| Schneider, A | 1 |
| Sperling, C | 1 |
| Heang, TM | 1 |
| Pons, M | 1 |
| Sousa, PJ | 1 |
| Kherad, B | 1 |
| Waliszewski, M | 1 |
| Kim, MH | 1 |
| Cha, KS | 1 |
| Han, JY | 1 |
| Kim, HJ | 1 |
| Kim, JS | 1 |
| Markell, MS | 1 |
| Homel, P | 1 |
| Sumrani, N | 1 |
| Hong, JH | 1 |
| Distant, DA | 1 |
| Miles, AM | 1 |
| Sommer, BG | 1 |
| Friedman, EA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Coroflex ISAR 2000 Postmarket Surveillance Non-Interventional Study[NCT02629575] | 2,877 participants (Actual) | Observational [Patient Registry] | 2014-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for probucol and Complication, Postoperative
| Article | Year |
|---|---|
Effect of antioxidant probucol for preventing stent restenosis.
Topics: Aged; Antioxidants; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Ar | 2002 |
Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.
Topics: Actuarial Analysis; Anticholesteremic Agents; Cholesterol; Chromatography, High Pressure Liquid; Cyc | 1998 |
1 other study available for probucol and Complication, Postoperative
| Article | Year |
|---|---|
Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture.
Topics: Aged; Aged, 80 and over; Asia; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; | 2018 |